查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1279777

2022-2029年全球迷幻藥市場規模研究和預測，按藥物類型、應用、配銷通路和區域分析。

Global Psychedelic Drugs Market Size study & Forecast, by Drug Type by Application, By Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

迷幻藥，也稱為致幻劑，是一類改變感知、情緒和認知過程的精神活性物質。它們在思想、情緒和感官知覺方面產生深刻的變化，經常引起意識狀態、神秘體驗和強烈情緒的改變。迷幻藥的常見例子包括 LSD、裸蓋菇素蘑菇、美斯卡林、DMT 和死藤水。由於與心理健康相關的政府舉措、聯盟和意識計劃等因素以及迷幻藥物研發的增加，迷幻藥市場正在擴大。

在預測期內，市場擴張的主要驅動力之一是心理健康困難的普遍存在，這就需要使用迷幻藥物來治療焦慮和抑鬱、精神病和某些類型的恐慌症等疾病。例如，根據《2022年美國心理健康狀況》報告，與2021年的數據集相比，有嚴重重度抑鬱症發作（MDE）的年輕人多了197,000人。因此，抑鬱症發病率的上升助長了對迷幻藥需求的上升，這反過來又刺激了預測期內的市場擴張。此外，產品批准的上升和迷幻藥物研究中心的發展上升。此外，產品批准的增加和迷幻藥研究中心的發展正在為市場創造一個有利的增長。然而，在2022-2029年的預測期內，迷幻藥的高副作用和嚴格的藥物行銷監管框架抑制了市場的增長。

全球迷幻藥市場研究涵蓋的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於品牌產品的主導地位和該地區日益增長的疾病流行率，北美在收入方面主導了市場。而亞太地區在預測期內預計將以最高的複合年增長率增長，這是因為目標人群不斷增加，合作開發產品的數量增加，主要參與者的地理擴張，以及政府和非營利組織在市場空間的積極參與等因素。

該研究的目的是確定近年來不同領域和國家的市場規模，並預測未來幾年的價值。該報告旨在將研究涉及的國家內的行業的品質和數量方面都涵蓋其中。

該報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來增長。此外，它還涵蓋了微觀市場的潛在機會，供利益相關者投資，以及對主要參與者的競爭格局和藥物類型產品的詳細分析。 .

目錄

第一章：執行摘要

  • 市場簡介
  • 2019-2029年全球和細分市場的估計和預測
    • 2019-2029年，按地區分類的迷幻藥市場
    • 2019-2029年，按藥物類型分類的迷幻藥市場
    • 2019-2029年迷幻藥市場，按應用分類
    • 2019-2029年，按配銷通路分類的迷幻藥市場
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章：全球迷幻藥市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 研究的範圍
    • 行業演變
  • 研究涵蓋的年份
  • 貨幣兌換率

第三章：全球迷幻藥市場動態

  • 迷幻藥市場影響分析（2019-2029年）
    • 市場驅動力
      • 與與心理健康相關的政府計劃、聯盟和意識計劃。
      • 迷幻藥物的研究和開發的上升。
    • 市場挑戰
      • 迷幻藥的大量副作用
      • 嚴格的藥物行銷監管框架
    • 市場機會
      • 產品獲批數量增加
      • 迷幻藥研究中心的不斷發展

第四章：全球迷幻藥市場行業分析

  • 波特五力模型
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力模型的未來方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 經濟
    • 社會
    • 技術
  • 最佳投資機會
  • 最佳策略
  • 行業專家展望
  • 分析師建議和結論

第五章：風險評估：COVID-19的影響

  • 評估COVID-19對行業的整體影響
  • COVID-19前和COVID-19後的市場情況

第六章：全球迷幻藥市場，按藥物類型分類

  • 市場簡介
  • 按藥物類型分類的全球迷幻藥市場，性能-潛力分析
  • 2019-2029年全球迷幻藥市場按藥物類型的估計和預測
  • 迷幻藥市場，細項分析
    • γ-羥丁酸（GHB）
    • 氯胺酮
    • 迷幻藥（Psilocybin
    • 麥角酸二乙胺(LSD)
    • 3,4-甲基乙二氧基甲基苯丙胺
    • 其他藥物類型

第7章：全球迷幻藥市場，按應用分類

  • 市場簡介
  • 按應用分類的全球迷幻藥市場，表現- 潛力分析
  • 2019-2029年全球迷幻藥市場按應用的估計和預測
  • 迷幻藥市場，次級細項分析
    • 耐受治療的抑鬱症
    • 鴉片劑成癮
    • 創傷後應激障礙
    • 嗜睡症
    • 恐慌症
    • 其他應用

第八章：全球迷幻藥市場，按配銷通路分類

  • 市場簡介
  • 按配銷通路分類的全球迷幻藥市場，表現- 潛力分析
  • 2019-2029年全球迷幻藥市場按配銷通路的估計和預測
  • 迷幻藥市場，次級細項分析
    • 醫院藥房
    • 零售藥店
    • 其他配銷通路

第九章：全球迷幻藥市場，區域分析

  • 迷幻藥市場，區域市場簡介
  • 北美洲
    • 美國。
      • 2019-2029年藥物類型細分的估計和預測
      • 2019-2029年，應用細分的估計和預測
      • 2019-2029年，配銷通路細分的估計和預測
    • 加拿大
  • 歐洲迷幻藥市場簡介
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區迷幻藥市場簡介
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉丁美洲迷幻藥市場簡況
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 世界其他地區

第十章：競爭情報

  • 頂級市場戰略
  • 公司簡介
    • Jazz Pharmaceuticals
      • 關鍵資訊
      • 概況
      • 財務（取決於數據的可用性）
      • 產品摘要
      • 近期發展情況
    • NeonMind BioSciences
    • Cybin Corp.
    • Pfizer Inc.
    • Numinus
    • Mind Medicine
    • PharmaTher Holdings Ltd
    • NRx Pharmaceuticals Inc.
    • Seelos Therapeutics
    • Havn Life

第十一章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Psychedelic Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Psychedelic drugs, also known as hallucinogens, are a class of psychoactive substances that alter perception, mood, and cognitive processes. They produce profound changes in thought, mood, and sensory perception, often inducing altered states of consciousness, mystical experiences, and intense emotions. Common examples of psychedelic drugs include LSD, psilocybin mushrooms, mescaline, DMT, and ayahuasca. The Psychedelic Drugs market is expanding because of factors such as government initiatives, alliances, and awareness programs associated with mental health and rise in research and development of psychedelic drugs.

One of the main drivers of market expansion during the forecast period is the prevalence of mental health difficulties, which call for the use of psychedelic medications to treat conditions like anxiety and depression, psychosis, and some types of panic attacks. For instance, according to the State of Mental Health in America 2022 report, there were 197,000 more young people who had a severe major depressive episode (MDE) than there were in the 2021 dataset. As a result, the rising prevalence of depressive disorders fuels a rise in the demand for psychedelic medications, which in turn spurs market expansion over the projection period. Furthermore, a rise in product approvals and rising development of psychedelic drugs research center. In addition, a rise in product approvals and rising development of psychedelic drugs research centre is creating a lucrative growth to the market. However, high number of side effects of psychedelic drug and stringent regulatory framework for drug marketing stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Psychedelic Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Jazz Pharmaceuticals
  • NeonMind BioSciences
  • Cybin Corp.
  • Pfizer Inc.
  • Numinus
  • Mind Medicine
  • PharmaTher Holdings Ltd
  • NRx Pharmaceuticals Inc.
  • Seelos Therapeutics
  • Havn Life

Recent Developments in the Market:

  • In October 2022, Numinus Wellness Inc., a supplier of mental health services that promotes new treatments and safe, evidence-based psychedelic-assisted therapies, launched the Ketamine for Chronic and Serious Medical Illness Programme. This new initiative will likely debut at the Numinus clinics in Utah, British Columbia, and Quebec. The company will expand the scheme to more clinics in the upcoming months.
  • In March 2022, University of California researchers published the findings and follow-up information from a phase 3 clinical trial using the psychedelic substance 3,4-methylenedioxymethamphetamine (MDMA) in conjunction with psychotherapy to treat post-traumatic stress disorder (PTSD). Their preliminary findings suggested that the therapy is effective even for people who are difficult to treat, like those who have drug or alcohol use disorders.

Global Psychedelic Drugs Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Type, Application, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Drug Type offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Type:

  • Gamma Hydroxybutyric Acid (GHB)
  • Ketamine
  • Psilocybin
  • Lysergic Acid Diethylamide (LSD),
  • 3,4-MethylEnedioxyMethamphetamine
  • Other Drug Types

By Application:

  • Treatment Resistant Depression
  • Opiate Addiction
  • Post-traumatic Stress Disorder
  • Narcolepsy
  • Panic Disorders
  • Other Applications

By Distribution Channel:

  • Hospital pharmacy
  • Retail pharmacy
  • Other Distribution Channels

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Psychedelic Drugs Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Psychedelic Drugs Market, by Drug Type, 2019-2029 (USD Billion)
    • 1.2.3. Psychedelic Drugs Market, by Application, 2019-2029 (USD Billion)
    • 1.2.4. Psychedelic Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Psychedelic Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Psychedelic Drugs Market Dynamics

  • 3.1. Psychedelic Drugs Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Government initiatives, alliances, and awareness programs associated with mental health.
      • 3.1.1.2. Rise in Research and Development of Psychedelic Drugs
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Number of Side Effects of Psychedelic Drug
      • 3.1.2.2. Stringent Regulatory Framework for Drug Marketing
    • 3.1.3. Market Opportunities
      • 3.1.3.1. A rise in product approvals
      • 3.1.3.2. Rising development of psychedelic drugs research centre

Chapter 4. Global Psychedelic Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Psychedelic Drugs Market, by Drug Type

  • 6.1. Market Snapshot
  • 6.2. Global Psychedelic Drugs Market by Drug Type, Performance - Potential Analysis
  • 6.3. Global Psychedelic Drugs Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
  • 6.4. Psychedelic Drugs Market, Sub Segment Analysis
    • 6.4.1. Gamma Hydroxybutyric Acid (GHB)
    • 6.4.2. Ketamine
    • 6.4.3. Psilocybin
    • 6.4.4. Lysergic Acid Diethylamide (LSD)
    • 6.4.5. 3,4- MethylEnedioxyMethamphetamine
    • 6.4.6. Other Drug Types

Chapter 7. Global Psychedelic Drugs Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Psychedelic Drugs Market by Application, Performance - Potential Analysis
  • 7.3. Global Psychedelic Drugs Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Psychedelic Drugs Market, Sub Segment Analysis
    • 7.4.1. Treatment Resistant Depression
    • 7.4.2. Opiate Addiction
    • 7.4.3. Post-traumatic Stress Disorder
    • 7.4.4. Narcolepsy
    • 7.4.5. Panic Disorders
    • 7.4.6. Other Applications

Chapter 8. Global Psychedelic Drugs Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Psychedelic Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Psychedelic Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Psychedelic Drugs Market, Sub Segment Analysis
    • 8.4.1. Hospital pharmacy
    • 8.4.2. Retail pharmacy
    • 8.4.3. Other Distribution Channels

Chapter 9. Global Psychedelic Drugs Market, Regional Analysis

  • 9.1. Psychedelic Drugs Market, Regional Market Snapshot
  • 9.2. North America Psychedelic Drugs Market
    • 9.2.1. U.S. Psychedelic Drugs Market
      • 9.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Psychedelic Drugs Market
  • 9.3. Europe Psychedelic Drugs Market Snapshot
    • 9.3.1. U.K. Psychedelic Drugs Market
    • 9.3.2. Germany Psychedelic Drugs Market
    • 9.3.3. France Psychedelic Drugs Market
    • 9.3.4. Spain Psychedelic Drugs Market
    • 9.3.5. Italy Psychedelic Drugs Market
    • 9.3.6. Rest of Europe Psychedelic Drugs Market
  • 9.4. Asia-Pacific Psychedelic Drugs Market Snapshot
    • 9.4.1. China Psychedelic Drugs Market
    • 9.4.2. India Psychedelic Drugs Market
    • 9.4.3. Japan Psychedelic Drugs Market
    • 9.4.4. Australia Psychedelic Drugs Market
    • 9.4.5. South Korea Psychedelic Drugs Market
    • 9.4.6. Rest of Asia Pacific Psychedelic Drugs Market
  • 9.5. Latin America Psychedelic Drugs Market Snapshot
    • 9.5.1. Brazil Psychedelic Drugs Market
    • 9.5.2. Mexico Psychedelic Drugs Market
    • 9.5.3. Rest of Latin America Psychedelic Drugs Market
  • 9.6. Rest of The World Psychedelic Drugs Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Jazz Pharmaceuticals
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. NeonMind BioSciences
    • 10.2.3. Cybin Corp.
    • 10.2.4. Pfizer Inc.
    • 10.2.5. Numinus
    • 10.2.6. Mind Medicine
    • 10.2.7. PharmaTher Holdings Ltd
    • 10.2.8. NRx Pharmaceuticals Inc.
    • 10.2.9. Seelos Therapeutics
    • 10.2.10. Havn Life

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Psychedelic Drugs Market, report scope
  • TABLE 2. Global Psychedelic Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Psychedelic Drugs Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
  • TABLE 4. Global Psychedelic Drugs Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Psychedelic Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Psychedelic Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Psychedelic Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Psychedelic Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Psychedelic Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Psychedelic Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Psychedelic Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Psychedelic Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Psychedelic Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Psychedelic Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Psychedelic Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Psychedelic Drugs Market
  • TABLE 71. List of primary sources, used in the study of global Psychedelic Drugs Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Psychedelic Drugs Market, research methodology
  • FIG 2. Global Psychedelic Drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Psychedelic Drugs Market, key trends 2021
  • FIG 5. Global Psychedelic Drugs Market, growth prospects 2022-2029
  • FIG 6. Global Psychedelic Drugs Market, porters 5 force model
  • FIG 7. Global Psychedelic Drugs Market, pest analysis
  • FIG 8. Global Psychedelic Drugs Market, value chain analysis
  • FIG 9. Global Psychedelic Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Psychedelic Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Psychedelic Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Psychedelic Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Psychedelic Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Psychedelic Drugs Market, regional snapshot 2019 & 2029
  • FIG 15. North America Psychedelic Drugs Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Psychedelic Drugs Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Psychedelic Drugs Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Psychedelic Drugs Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Psychedelic Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable